EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NF-κB: Governing Macrophages in Cancer

Jessica Cornice, Daniela Verzella iD, Paola Arboretto iD, Davide Vecchiotti iD, Daria Capece iD, Francesca Zazzeroni, Guido Franzoso iD

Genes · 31.01.2024 · 15 (2) · 197

DOI: 10.3390/genes15020197 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 31.01.2024. Verfasst von Jessica Cornice und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK. Hauptthemen laut MEDLINE: NF-kappa B, Neoplasms. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Cancer Research UK, NIHR Imperial Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) are the major component of the tumor microenvironment (TME), where they sustain tumor progression and or-tumor immunity. Due to their plasticity, macrophages can exhibit anti- or pro-tumor functions through the expression of different gene sets leading to distinct macrophage phenotypes: M1-like or pro-inflammatory and M2-like or anti-inflammatory. NF-κB transcription factors are central regulators of TAMs in cancers, where they often drive macrophage polarization toward an M2-like phenotype. Therefore, the NF-κB pathway is an attractive therapeutic target for cancer immunotherapy in a wide range of human tumors. Hence, targeting NF-κB pathway in the myeloid compartment is a potential clinical strategy to overcome microenvironment-induced immunosuppression and increase anti-tumor immunity. In this review, we discuss the role of NF-κB as a key driver of macrophage functions in tumors as well as the principal strategies to overcome tumor immunosuppression by targeting the NF-κB pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BNeoplasmsHumansMacrophagesNF-kappa B p50 SubunitPhenotypeTumor Microenvironment

Stichwörter der Autor:innen

NF-κBtumor microenvironment (TME)tumor-associated macrophages (TAMs)

Substanzen

NF-kappa BNF-kappa B p50 Subunit

Autor:innen und Institutionen

  • Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK.
  • Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, 67100 L'Aquila, Italy.

ORCID-Profile: Daniela Verzella, Paola Arboretto, Davide Vecchiotti, Daria Capece, Guido Franzoso

Förderung

  • Medical Research Council
  • Cancer Research UK
  • NIHR Imperial Biomedical Research Centre
  • Imperial College London Joint Translational Fund, Medical Research Council (MRC) and Yuhan Corporation, Imperial Confidence in Concept (ICiC) 2021
  • Intramural DISCAB GRANT 2023, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila
  • Progetto di Ateneo per la Ricerca di Base 2022, University of L’Aquila

Zitieren

APA

Cornice, J., Verzella, D., Arboretto, P., Vecchiotti, D., Capece, D., Zazzeroni, F., & Franzoso, G. (2024). NF-κB: Governing Macrophages in Cancer. Genes, 15(2), 197. https://doi.org/10.3390/genes15020197

Vancouver

Cornice J, Verzella D, Arboretto P, Vecchiotti D, Capece D, Zazzeroni F, et al. NF-κB: Governing Macrophages in Cancer. Genes. 2024;15(2):197. doi:10.3390/genes15020197

BibTeX
@article{Cornice2024,
  author = {Cornice, Jessica and Verzella, Daniela and Arboretto, Paola and Vecchiotti, Davide and Capece, Daria and Zazzeroni, Francesca and Franzoso, Guido},
  title = {NF-κB: Governing Macrophages in Cancer},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {2},
  pages = {197},
  doi = {10.3390/genes15020197}
}
Kostenlos starten →